Where can I get compounded Compounded Sermorelin Sublingual — M&P Variant?

Compounded Sermorelin Sublingual — M&P Variant is available through licensed compounding pharmacies on the SlimionRX network. Visit slimionrx.com to find a pharmacy near you.

Compounded Sermorelin Sublingual — M&P Variant 2 mg / mL (Mortar & Pestle Process) — Compounded Sublingual Liquid Patient Monograph

Patient education monograph for Compounded Sermorelin Sublingual — M&P Variant (2 mg / mL (Mortar & Pestle Process)), a compounded sublingual liquid. Learn how it works, how to use it, possible side effects, and find a licensed compounding pharmacy near you.

What is Compounded Sermorelin Sublingual — M&P Variant?

This compounded preparation contains sermorelin 2 mg per mL in a sublingual liquid base, prepared using a traditional Mortar & Pestle compounding process by a licensed compounding pharmacy pursuant to a valid individual patient prescription. This variant uses the same active ingredient and dosing as the standard sermorelin sublingual preparation but employs a specific compounding methodology designed for optimal peptide incorporation. It is used in provider-directed growth hormone-stimulating protocols. Compounded sermorelin is not an FDA-approved product. Formula developed in partnership with

How does Compounded Sermorelin Sublingual — M&P Variant work?

Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on somatotroph cells in the anterior pituitary, stimulating pulsatile secretion of the body's own natural growth hormone — preserving physiologic feedback regulation in contrast to exogenous GH administration. IGF-1 mediates many of growth hormone's anabolic and metabolic downstream effects. The Mortar & Pestle process ensures complete peptide dispersion in the sublingual base for consistent dosing.

How to use Compounded Sermorelin Sublingual — M&P Variant

Administer at bedtime on an empty stomach as directed by your prescriber. Place the dose under the tongue and hold for at least 60 seconds before swallowing. Avoid eating, drinking, or rinsing your mouth for at least 10 minutes after administration. Bedtime use aligns with the body's natural nocturnal growth hormone secretion pattern. Do not adjust the dose without prescriber guidance.

Compounded Sermorelin Sublingual — M&P Variant side effects

Headache, flushing, dizziness, mild nausea, and joint discomfort may occur, particularly at higher doses or during initiation. Transient water retention (peripheral edema) has been reported. These effects typically improve with dose adjustment. Contact your prescriber if side effects are persistent, bothersome, or interfering with daily activities.

Drug interactions with Compounded Sermorelin Sublingual — M&P Variant

Glucocorticoids may suppress the pituitary response to sermorelin and reduce efficacy. Thyroid hormone status can affect GH axis sensitivity. Insulin resistance affects sermorelin response — optimize metabolic parameters where possible. Inform your prescriber of all current medications, particularly steroids, thyroid medications, and hormonal therapies.

How to store Compounded Sermorelin Sublingual — M&P Variant

Refrigerate at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. Keep tightly closed. Use within the beyond-use date printed on the label. Discard if the solution appears cloudy, discolored, or contains particulate matter.

Precautions for Compounded Sermorelin Sublingual — M&P Variant

Do not use if active malignancy is present or suspected — growth hormone stimulation may be contraindicated. Exercise caution in patients with diabetes or significant insulin resistance. Safety in pregnancy and breastfeeding has not been established. Long-term safety data for sublingual sermorelin is limited — discuss benefit-risk with your prescriber. Keep out of reach of children.

Frequently Asked Questions — Compounded Sermorelin Sublingual — M&P Variant

What is Compounded Sermorelin Sublingual — M&P Variant?: This compounded preparation contains sermorelin 2 mg per mL in a sublingual liquid base, prepared using a traditional Mortar & Pestle compounding process by a licensed compounding pharmacy pursuant to a valid individual patient prescription. This variant uses the same active ingredient and dosing as the standard sermorelin sublingual preparation but employs a specific compounding methodology designed for optimal peptide incorporation. It is used in provider-directed growth hormone-stimulating pr
How does Compounded Sermorelin Sublingual — M&P Variant work?: Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on somatotroph cells in the anterior pituitary, stimulating pulsatile secretion of the body's own natural growth hormone — preserving physiologic feedback regulation in contrast to exogenous GH administration. IGF-1 mediates many of growth hormone's anabolic and metabolic downstream effects. The Mortar & Pestle process ensures complete peptide dispersio
How do I use Compounded Sermorelin Sublingual — M&P Variant?: Administer at bedtime on an empty stomach as directed by your prescriber. Place the dose under the tongue and hold for at least 60 seconds before swallowing. Avoid eating, drinking, or rinsing your mouth for at least 10 minutes after administration. Bedtime use aligns with the body's natural nocturnal growth hormone secretion pattern. Do not adjust the dose without prescriber guidance.
What are the side effects of Compounded Sermorelin Sublingual — M&P Variant?: Headache, flushing, dizziness, mild nausea, and joint discomfort may occur, particularly at higher doses or during initiation. Transient water retention (peripheral edema) has been reported. These effects typically improve with dose adjustment. Contact your prescriber if side effects are persistent, bothersome, or interfering with daily activities.
Are there drug interactions with Compounded Sermorelin Sublingual — M&P Variant?: Glucocorticoids may suppress the pituitary response to sermorelin and reduce efficacy. Thyroid hormone status can affect GH axis sensitivity. Insulin resistance affects sermorelin response — optimize metabolic parameters where possible. Inform your prescriber of all current medications, particularly steroids, thyroid medications, and hormonal therapies.
How should I store Compounded Sermorelin Sublingual — M&P Variant?: Refrigerate at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. Keep tightly closed. Use within the beyond-use date printed on the label. Discard if the solution appears cloudy, discolored, or contains particulate matter.
What precautions should I know about Compounded Sermorelin Sublingual — M&P Variant?: Do not use if active malignancy is present or suspected — growth hormone stimulation may be contraindicated. Exercise caution in patients with diabetes or significant insulin resistance. Safety in pregnancy and breastfeeding has not been established. Long-term safety data for sublingual sermorelin is limited — discuss benefit-risk with your prescriber. Keep out of reach of children.
Where can I get compounded Compounded Sermorelin Sublingual — M&P Variant?: Compounded Sermorelin Sublingual — M&P Variant is available through licensed compounding pharmacies on the SlimionRX network. Visit slimionrx.com to find a pharmacy near you.